Crossmark

Beyond-Mild Psoriasis: A Consensus Statement on Calcipotriol and Betamethasone Dipropionate Foam for the Topical Treatment of Adult Patients

Crossref DOI link: https://doi.org/10.1007/s13555-021-00600-1

Published Online: 2021-09-12

Published Print: 2021-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aschoff, Roland https://orcid.org/0000-0002-5740-8651
Bewley, Anthony https://orcid.org/0000-0003-1195-0290
Dattola, Annunziata https://orcid.org/0000-0001-9504-5882
De Simone, Clara https://orcid.org/0000-0002-0898-0045
Lahfa, Mourad

Llamas-Velasco, Mar https://orcid.org/0000-0002-1187-1341
Martorell, Antonio https://orcid.org/0000-0003-1378-1590
Pavlovic, Mira

Sticherling, Michael https://orcid.org/0000-0001-9396-3938
Funding

Funding for this research was provided by:

LEO Pharma
License Information

Text and Data Mining valid from 2021-09-12

Version of Record valid from 2021-09-12
More Information

Article History

Received: 12 April 2021

Accepted: 19 August 2021

First Online: 12 September 2021